Publication | Closed Access

A multinational, randomized phase iii trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy

OncologyRadiation TherapyHead-and-neck MalignancyHead And Neck CancerOral MucositisNeck OncologyMedicineRadiation OncologyCancer ResearchOral Cancer